ARVINDER ARORA: Open Payments
NPI 1740294370 · EFFINGHAM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 12 payments from 7 companies in 2025. Trend: 2023 $1,184 · 2024 $694 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Viatris Specialty LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $16 |
Products named: TEZSPIRE, QULIPTA, LINZESS, YUPELRI, Wegovy, MOUNJARO, Kerendia, FASENRA.
Industry payments across IL — which companies pay providers there.
